<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Latest Technologies - Isis Innovation</title>
    <link>http://www.isis-innovation.com/licensing/new.html</link>
    <description>Up to date announcements of the latest technologies from the University of Oxford</description>
    <item>
       <title>Safe Cardioprotective Treatment</title>
       <link>http://www.isis-innovation.com/licensing/8034.html</link>
       <description>A treatment that prevents damage following heart attacks based on a well-tolerated compound.</description>
    </item>
    <item>
       <title>Epitope Identification</title>
       <link>http://www.isis-innovation.com/licensing/7260.html</link>
       <description>A platform that mimics the conditions for in vivo antigen presentation with the potential to identify epitopes recognised by T-cells or NK-cells of completely unknown specificity. Applications include the identification of therapeutic targets, vaccine development and diagnostic assays.</description>
    </item>
    <item>
       <title>New Process for DCDP Polymerisation</title>
       <link>http://www.isis-innovation.com/licensing/77379.html</link>
       <description>An air-stable, non-toxic, Ru-based organometallic catalyst for the production of poly-dicyclopentadiene (pDCPD).</description>
    </item>
    <item>
       <title>Reversible Proton-pump Inhibitor</title>
       <link>http://www.isis-innovation.com/licensing/79115.html</link> 
       <description>Innovative anti-ulcer drug to replace proton pump inhibitors on basis of high antisecretory activity and significantly reduced side-effects.</description>
    </item>
    <item>
       <title>Statin-induced Myopathy Diagnostic</title>
       <link>http://www.isis-innovation.com/licensing/3542.html</link>
       <description>A simple diagnostic method to identify individuals at increased risk of statin-induced myopathy, a potential side-effect for many users of the cholesterol lowering drug.</description>
    </item>
    <item>
       <title>Novel Antibacterial Target</title>
       <link>http://www.isis-innovation.com/licensing/7401.html</link> 
       <description>A newly discovered enzyme has the potential to combat difficult to treat, multi drug-resistant bacterial infections.</description>
    </item>
    <item>
       <title>'Stealth' Antibody Technology</title>
       <link>http://www.isis-innovation.com/licensing/689.html</link> 
       <description>Technology for producing therapeutic antibodies that do not illicit an immune response, have reduced side effects and can be activated site-specifically.</description>
    </item>
    <item>
       <title>Acute Myeloid Leukaemia Biomarkers</title>
       <link>http://www.isis-innovation.com/licensing/4130.html</link>
       <description>Unique combination of cell-surface biomarkers for Acute Myeloid Leukaemia (AML) diagnostic and prognostic screening. The biomarkers provide improved sensitivity in AML diagnosis and prognosis.</description>
    </item>
    <item>
       <title>Improved Ceramic Price/Performance</title>
       <link>http://www.isis-innovation.com/licensing/7097.html</link>
       <description>A scalable process for manufacturing a new engineering ceramic combining the cost-effectiveness of alumina with the performance characteristics of expensive alternatives such as alumina-silicon carbide.</description>
    </item>
    <item>
       <title>Stronger, Tougher Alumina</title>
       <link>http://www.isis-innovation.com/licensing/4211.html</link> 
       <description>A scalable process for manufacturing a new class of engineering ceramics, combining the cost-effectiveness of alumina with the performance characteristics of expensive alternatives such as silicon carbide.</description>
    </item>
    <item>
       <title>Acute Myeloid Leukaemia Biomarkers</title>
       <link>http://www.isis-innovation.com/licensing/4130.html</link>
       <description>Unique combination of cell-surface biomarkers for Acute Myeloid Leukaemia (AML) diagnostic and prognostic screening. The biomarkers provide improved sensitivity in AML diagnosis and prognosis.</description>
    </item>
    <item>
       <title>Better Gearbox Monitoring</title>
       <link>http://www.isis-innovation.com/licensing/8347.html</link>
       <description>An approach that provides for direct characterisation of the surface condition of the gears themselves which can be used alone or in combination with established sensing technologies to improve monitoring of gearboxes in applications such as wind turbines.</description>
    </item>
    <item>
       <title>Disease Control for Aquaculture</title>
       <link>http://www.isis-innovation.com/licensing/77841.html</link>
       <description>An alternative to antibiotics to treat infectious diseases caused by bacteria, for application in aquaculture and other animal farming sectors.</description>
    </item>
    <item>
       <title>Nanocomposite Carpets</title>
       <link>http://www.isis-innovation.com/licensing/4301.html</link>
       <description>Industrial scale production of aligned carbon nanotube/glass composite carpets. The invention involves a technique to modify the structural features of nanotubes, making them suitable for thermal interface materials for heat sinks, thermal/gas/electrical sensors, high performance brake pads and molecular filters.</description>
    </item>
  </channel>
</rss> 
